Ara
Toplam kayıt 3, listelenen: 1-3
An update on the drug safety of treating erectile dysfunction
(Taylor & Francis, 2019)
Introduction: Treatment options for erectile dysfunction (ED) have evolved over the last two decades, particularly after the introduction of phosphodiesterase type-5 inhibitors (PDE5Is). The path, however, has not been ...
Fingolimod for the treatment of relapsing-remitting multiple sclerosis
(Turkish Neurological Society, 2017)
Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system and is characterized by inflammation, demyelination, and axonal loss. Fingolimod is the first oral drug for the treatment of MS approved ...
Oxytocin antagonists: The next frontier in PE treatment
(Nature Publishing Group, 2019)
Oxytocin antagonists seem to have potential as a treatment option for premature ejaculation (PE), but the parameters of their use are vague. Two recently published studies highlight the need for large-scale trials to ...